Foghorn Therapeutics (FHTX) has issued an update.
Foghorn Therapeutics Inc. is sharing a new investor presentation as part of a recent report, detailing their strategic plans and updates. This information, while not filed for regulatory purposes, offers valuable insights for investors tracking the company’s progress and future prospects in the biotechnology sector.
See more data about FHTX stock on TipRanks’ Stock Analysis page.
